These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pentoxifylline--a new drug for the treatment of intermittent claudication. Chopra HK, Chopra KL, Aggarwal KK, Parashar SK. Indian Heart J; 1989; 41(2):127-33. PubMed ID: 2744799 [Abstract] [Full Text] [Related]
11. Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group. Dettori AG, Pini M, Moratti A, Paolicelli M, Basevi P, Quintavalla R, Manotti C, Di Lecce C. Angiology; 1989 Apr; 40(4 Pt 1):237-48. PubMed ID: 2650578 [Abstract] [Full Text] [Related]
12. On the assessment of the efficacy of pentoxifylline (Trental). Rössner M, Müller R. J Med; 1987 Apr; 18(1):1-15. PubMed ID: 3298515 [Abstract] [Full Text] [Related]
15. Influence of pentoxifylline on muscle tissue oxygen tension (pO2) of patients with intermittent claudication before and after pedal ergometer exercise. Ehrly AM, Saeger-Lorenz K. Angiology; 1987 Feb; 38(2 Pt 1):93-100. PubMed ID: 3548493 [Abstract] [Full Text] [Related]
17. Placebo controlled double blind study with pentoxifylline of walking performance in patients with intermittent claudication. Di Perri T, Guerrini M. Angiology; 1983 Jan; 34(1):40-5. PubMed ID: 6824189 [Abstract] [Full Text] [Related]
18. Pentoxifylline treatment of moderate to severe chronic occlusive arterial disease. Lee BY, Berkowitz P, Savitsky JP, May GS, Brobst J, McCann WJ. Clin Cardiol; 1985 Mar; 8(3):161-5. PubMed ID: 3978888 [Abstract] [Full Text] [Related]